Literature DB >> 31070458

Letter to the Editor: Not all modified citrus pectins are the same: size does matter.

Isaac Eliaz1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31070458      PMCID： PMC6580396          DOI： 10.1152/ajpheart.00118.2019

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  18 in total

1.  Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells.

Authors:  Nashwa M Abu-Elsaad; Wagdi Fawzi Elkashef
Journal:  Can J Physiol Pharmacol       Date:  2015-12-16       Impact factor: 2.273

2.  Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.

Authors:  Ernesto Martínez-Martínez; Natalia López-Ándres; Raquel Jurado-López; Elodie Rousseau; Mará Visitación Bartolomé; Amaya Fernández-Celis; Patrick Rossignol; Fabian Islas; Alfonso Antequera; Santiago Prieto; María Luaces; Victoria Cachofeiro
Journal:  Hypertension       Date:  2015-09-08       Impact factor: 10.190

3.  The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.

Authors:  Laurent Calvier; Ernesto Martinez-Martinez; Maria Miana; Victoria Cachofeiro; Elodie Rousseau; J Rafael Sádaba; Faiez Zannad; Patrick Rossignol; Natalia López-Andrés
Journal:  JACC Heart Fail       Date:  2014-11-11       Impact factor: 12.035

4.  Galectin-3 inhibition prevents adipose tissue remodelling in obesity.

Authors:  E Martínez-Martínez; L Calvier; P Rossignol; E Rousseau; A Fernández-Celis; R Jurado-López; M Laville; V Cachofeiro; N López-Andrés
Journal:  Int J Obes (Lond)       Date:  2016-02-08       Impact factor: 5.095

5.  Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.

Authors:  Ernesto Martínez-Martínez; Laurent Calvier; Amaya Fernández-Celis; Elodie Rousseau; Raquel Jurado-López; Luciana V Rossoni; Frederic Jaisser; Faiez Zannad; Patrick Rossignol; Victoria Cachofeiro; Natalia López-Andrés
Journal:  Hypertension       Date:  2015-08-03       Impact factor: 10.190

6.  Galectin-3 mediates aldosterone-induced vascular fibrosis.

Authors:  Laurent Calvier; Maria Miana; Pascal Reboul; Victoria Cachofeiro; Ernesto Martinez-Martinez; Rudolf A de Boer; Françoise Poirier; Patrick Lacolley; Faiez Zannad; Patrick Rossignol; Natalia López-Andrés
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-01       Impact factor: 8.311

7.  Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury.

Authors:  Maria Kolatsi-Joannou; Karen L Price; Paul J Winyard; David A Long
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

8.  Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage.

Authors:  Ernesto Martinez-Martinez; Jaime Ibarrola; Laurent Calvier; Amaya Fernandez-Celis; Celine Leroy; Victoria Cachofeiro; Patrick Rossignol; Natalia Lopez-Andres
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

9.  Role for Galectin-3 in Calcific Aortic Valve Stenosis.

Authors:  J Rafael Sádaba; Ernesto Martínez-Martínez; Vanessa Arrieta; Virginia Álvarez; Amaya Fernández-Celis; Jaime Ibarrola; Amaia Melero; Patrick Rossignol; Victoria Cachofeiro; Natalia López-Andrés
Journal:  J Am Heart Assoc       Date:  2016-11-04       Impact factor: 5.501

10.  Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice.

Authors:  Yonggang Lu; Mingming Zhang; Pei Zhao; Min Jia; Bing Liu; Qian Jia; Jun Guo; Lin Dou; Jian Li
Journal:  Mol Med Rep       Date:  2017-05-29       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.